Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness

Alwin B P Noordman1, Michiel Rienstra1, Yuri Blaauw1

  • 1Department of Cardiology, Heart Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Insights

Many patients receive appropriate implantable cardioverter-defibrillator (ICD) therapy without loss of consciousness, potentially leading to unnecessary treatment. This can cause significant psychological distress, highlighting a need for better symptom assessment in ICD patients.

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Background:

  • Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden cardiac death.
  • Some appropriate ICD therapies may be unnecessary, delivered without symptoms like loss of consciousness.
  • Understanding patient-reported symptoms is key to evaluating ICD therapy appropriateness.

Purpose of the Study:

  • To determine the incidence of appropriate ICD therapy with loss of consciousness.
  • To assess the psychological impact of ICD therapy based on patient-reported symptoms.
  • To identify factors associated with appropriate ICD therapy and consciousness impairment.

Main Methods:

  • Prospective, single-center study of 100 consecutive ICD patients.
  • Patients received ICD shock and/or ATP within 6 months prior.
  • Questionnaires assessed patient-reported symptoms, focusing on loss of consciousness.

Main Results:

  • 92% of patients experienced appropriate ICD therapy.
  • Loss of consciousness occurred in 40% of patients with appropriate therapy (65% with shocks).
  • Patients without loss of consciousness reported greater anxiety post-shock (60.0% vs 42.9%).

Conclusions:

  • A significant number of patients receive appropriate ICD therapy without loss of consciousness.
  • This suggests potentially unnecessary therapy and associated psychological impact.
  • Further research is needed to refine ICD therapy delivery based on symptom presentation.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.3K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
507
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K